Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    NEXT STORY
    Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
    PREV STORY
    India Medical Plastics Market Size, Share & Trends Analysis Report By Product, By Application And Segment Forecasts, 2020 – 2030
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    XBiotech Announces Oral Presentation of Atopic Dermatitis Results for Bermekimab at 2019 EADV Congress in Madrid, Spain

    author_avatar
    NASDAQ Market News

    ProQR Announces Results for the First Quarter of 2017

    Key updates QR-010 Phase 1b clinical trial on track to present top-line data in ...

    author_avatar
    NASDAQ Market News

    Affimed Announces Milestone Payment from Genentech and ROCK® Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity

    author_avatar
    NASDAQ Market News